Maternal Hereditary Hemolytic Anemia and Birth Defects in the National Birth Defects Prevention Study

Overview

Journal Birth Defects Res

Specialties Reproductive Medicine
Toxicology

Date 2022 Mar 5

PMID 35247031

Authors

Eleni A Papadopoulos

Sarah C Fisher

Meredith M Howley

Marilyn L Browne

Affiliations

Soon will be listed here.

Abstract

Objectives: Hereditary hemolytic anemia (HHA) results from genetic mutations that cause red blood cell abnormalities. Little research exists on the relationship between HHA and birth defects. Using data from the National Birth Defects Prevention Study (NBDPS), we described characteristics of HHA-exposed women and estimated associations between HHA during pregnancy and specific birth defects.

Methods: The NBDPS was a population-based, case-control study of major birth defects and included pregnancies with estimated delivery dates from October 1997 through December 2011. Participants were ascertained from hospital discharge lists or birth defect registries at 10 sites. Trained interviewers collected information about pregnancy exposures via telephone questionnaire. We described characteristics among HHA-exposed women and calculated crude odds ratios and exact 95% confidence intervals for defects with ≥3 exposed cases.

Results: Among 31 HHA-exposed women (28 cases/3 controls), 13 (42%) reported sickle cell anemia, 17 (55%) reported thalassemia, and one (3%) reported hereditary spherocytosis. The average age at delivery for HHA-exposed case women was 27.3 years (range: 17-38). The majority (82%) of HHA-exposed case women reported additional conditions during pregnancy, including hypertension, genitourinary infections, and respiratory illnesses. Additionally, 93% of case women reported using medication during pregnancy. Among the 28 cases, 18 (64%) had isolated birth defects. The defects with ≥3 exposed cases were anencephaly, atrial septal defect, gastroschisis, and cleft palate. Except for anencephaly, the 95% confidence intervals for all estimates were close to or included the null.

Conclusion: This hypothesis-generating study adds to the sparse literature on the association between HHA and birth defects.

References

Petrakos G, Andriopoulos P, Tsironi M . Pregnancy in women with thalassemia: challenges and solutions. Int J Womens Health. 2016; 8:441-51. PMC: 5019437. DOI: 10.2147/IJWH.S89308. View

Kuo K, Caughey A . Contemporary outcomes of sickle cell disease in pregnancy. Am J Obstet Gynecol. 2016; 215(4):505.e1-5. DOI: 10.1016/j.ajog.2016.05.032. View

Yoon P, Rasmussen S, Lynberg M, Moore C, Anderka M, Carmichael S . The National Birth Defects Prevention Study. Public Health Rep. 2002; 116 Suppl 1:32-40. PMC: 1913684. DOI: 10.1093/phr/116.S1.32. View

Howley M, Feldkamp M, Papadopoulos E, Fisher S, Arnold K, Browne M . Maternal genitourinary infections and risk of birth defects in the National Birth Defects Prevention Study. Birth Defects Res. 2018; 110(19):1443-1454. PMC: 6543540. DOI: 10.1002/bdr2.1409. View

Botto L, Lin A, Riehle-Colarusso T, Malik S, Correa A . Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol. 2007; 79(10):714-27. DOI: 10.1002/bdra.20403. View

Lam Y, Tang M . Risk of neural tube defects in the offspring of thalassaemia carriers in Hong Kong Chinese. Prenat Diagn. 1999; 19(12):1135-7. View

Williams J, Mai C, Mulinare J, Isenburg J, Flood T, Ethen M . Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011. MMWR Morb Mortal Wkly Rep. 2015; 64(1):1-5. PMC: 4584791. View

Ibba R, Zoppi M, Floris M, Manca F, Axiana C, Cao A . Neural tube defects in the offspring of thalassemia carriers. Fetal Diagn Ther. 2003; 18(1):5-7. DOI: 10.1159/000066375. View

Alayed N, Kezouh A, Oddy L, Abenhaim H . Sickle cell disease and pregnancy outcomes: population-based study on 8.8 million births. J Perinat Med. 2013; 42(4):487-92. DOI: 10.1515/jpm-2013-0275. View

10.

Vichinsky E, Macklin E, Waye J, Lorey F, Olivieri N . Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics. 2005; 116(6):e818-25. DOI: 10.1542/peds.2005-0843. View

11.

Bencaiova G, Burkhardt T, Breymann C . Anemia--prevalence and risk factors in pregnancy. Eur J Intern Med. 2012; 23(6):529-33. DOI: 10.1016/j.ejim.2012.04.008. View

12.

Chen C, Grewal J, Betran A, Vogel J, Souza J, Zhang J . Severe anemia, sickle cell disease, and thalassemia as risk factors for hypertensive disorders in pregnancy in developing countries. Pregnancy Hypertens. 2018; 13:141-147. DOI: 10.1016/j.preghy.2018.06.001. View

13.

Vieth J, Lane D . Anemia. Emerg Med Clin North Am. 2014; 32(3):613-28. DOI: 10.1016/j.emc.2014.04.007. View

14.

Fozza C, Asara M, Vacca N, Caggiari S, Monti A, Zaccheddu F . Pregnancy Outcome among Women with Beta-Thalassemia Major in North Sardinia. Acta Haematol. 2017; 138(3):166-167. DOI: 10.1159/000480450. View

15.

Lee A, Okam M . Anemia in pregnancy. Hematol Oncol Clin North Am. 2011; 25(2):241-59, vii. DOI: 10.1016/j.hoc.2011.02.001. View

16.

Wang Y, Kennedy J, Caggana M, Zimmerman R, Thomas S, Berninger J . Sickle cell disease incidence among newborns in New York State by maternal race/ethnicity and nativity. Genet Med. 2012; 15(3):222-8. PMC: 4453875. DOI: 10.1038/gim.2012.128. View

17.

Castaldi G, Bagni B, Trotta F, Menegale G, Cavallini A, PIFFANELLI A . Folic acid deficiency in beta-thalassaemia heterozygotes. Scand J Haematol. 1983; 30(2):125-9. DOI: 10.1111/j.1600-0609.1983.tb01456.x. View

18.

Sorrentino F, Maffei L, Caprari P, Cassetta R, DellAnna D, Materazzi S . Pregnancy in Thalassemia and Sickle Cell Disease: The Experience of an Italian Thalassemia Center. Front Mol Biosci. 2020; 7:16. PMC: 7033579. DOI: 10.3389/fmolb.2020.00016. View

19.

Bornstein E, Eliner Y, Chervenak F, Grunebaum A . Concerning trends in maternal risk factors in the United States: 1989-2018. EClinicalMedicine. 2021; 29-30:100657. PMC: 8164172. DOI: 10.1016/j.eclinm.2020.100657. View

20.

McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B . Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2008; 12(4):444-54. DOI: 10.1017/S1368980008002401. View